Market
What will be the impact on ACA's no-cost HIV drugs coverage post-Supreme Court ruling by mid-2026?
2
Resolution / Starting Odds
No change • 25%
Partial coverage introduced • 25%
Full cost-sharing introduced • 25%
Coverage removed • 25%
Official ruling published by the U.S. Supreme Court or subsequent policy announcements
Story
Supreme Court to Review ACA's No-Cost Coverage for Cancer Screenings, Heart Statins, and HIV Drugs
Jan 10, 2025, 11:26 PM
The U.S. Supreme Court has agreed to review a challenge to the Affordable Care Act's (ACA) requirement for no-cost coverage of certain preventive care services, including cancer screenings, heart statins, and HIV drugs. The case, Braidwood Management, Inc. et al. v. Xavier Becerra, questions the constitutionality of the U.S. Preventive Services Task Force's authority to mandate such coverage. The challenge stems from a ruling by the 5th U.S. Circuit Court of Appeals, which found that the task force's structure violated the Appointments Clause of the U.S. Constitution because its members are not appointed by the president and confirmed by the Senate. The Supreme Court's decision to hear the case could impact the availability of these preventive services, which are currently covered without cost-sharing under the ACA.
View original story
Similar markets
Strike down ACA coverage as unconstitutional • 25%
Uphold ACA coverage as constitutional • 25%
Remand to lower court for further proceedings • 25%
Other • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Increase in states restricting funding • 25%
Decrease in states restricting funding • 25%
No significant change • 25%
Mixed outcomes • 25%
Decrease below 23 million • 25%
Other outcomes • 25%
Increase to over 25 million • 25%
Remain around 24 million • 25%
Unclear impact • 25%
Minimal impact • 25%
Significant restriction of rights • 25%
Significant expansion of rights • 25%
Other outcomes • 25%
Extended as is • 25%
Replaced by new measures • 25%
Allowed to expire • 25%
Minor adjustments • 25%
No changes • 25%
Other outcomes • 25%
Major repeal efforts • 25%
Decrease in similar bans • 25%
Increase in similar bans • 25%
No change in similar bans • 25%
Mixed changes • 25%
No significant change in states' laws • 25%
Other outcome • 25%
More than 10 states repeal similar laws • 25%
More than 10 states uphold similar laws • 25%
Yes • 50%
No • 50%
Decrease in availability • 25%
Increase in availability • 25%
No significant change in availability • 25%
Other • 25%